Events2Join

iSTAR Medical receives U.S. FDA approval to start pivotal trial for ...


iSTAR Medical receives U.S. FDA approval to start pivotal trial for ...

We are very pleased that the FDA has granted us approval to bring this innovative technology to North American patients suffering from primary ...

iSTAR Medical shows initial positive progress of US STAR-V trial for ...

iSTAR Medical receives U.S. FDA approval to start pivotal trial for MINIject in glaucoma patients ... By clicking “Accept All Cookies”, you agree ...

iSTAR Medical receives U.S. FDA approval to start pivotal trial for ...

The STAR-V study will investigate MINIject TM in over 350 patients with primary open angle glaucoma. World-leading glaucoma surgeons in the US, Canada and ...

iSTAR Medical receives U.S. FDA approval to start pivotal trial for ...

iSTAR Medical receives U.S. FDA approval to start pivotal trial for MINIject in glaucoma patients ... The STAR-V study will investigate MINIjectTM ...

iSTAR Medical receives US FDA approval to start pivotal

iSTAR Medical, a med-tech company developing minimally-invasive implants for glaucoma surgery (MIGS), announced today that the U.S. Food and ...

iSTAR Medical Receives FDA Approval to Begin Trial for MINIject for ...

“We are very pleased that the FDA has granted us approval to bring this innovative technology to North American patients suffering from ...

iSTAR Medical receives European market approval for glaucoma ...

iSTAR Medical receives U.S. FDA approval to start pivotal trial for MINIject in glaucoma patients ... By clicking “Accept All Cookies”, you agree ...

iSTAR Medical shows initial positive progress of US STAR-V

The STAR-V trial is a US FDA-approved pivotal study assessing the safety and efficacy of MINIject in over 350 patients with primary open-angle ...

FDA grants iStar Medical IDE for glaucoma implant pivotal trial

iSTAR Medical announced today that the FDA granted investigational device exemption to start a pivotal trial with its MINIject implant.

iSTAR Medical gets FDA nod to initiate trial of MINIject for glaucoma

iSTAR Medical has received investigational device exemption (IDE) from the US Food and Drug Administration (FDA) to commence a clinical trial of its minimally ...

AbbVie and iSTAR Medical Announce Strategic Alliance for the ...

MINIject® received Conformité Européenne (CE) marking approval to commercialize in European countries in the last quarter of 2021 and launched ...

iSTAR Medical on X: "iSTAR Medical received approval from the ...

iSTAR Medical received approval from the U.S. Food and Drug Administration (@US_FDA) to start a pivotal trial for #MINIject.

Gimv : ISTAR Medical receives U.S. FDA approval to start pivotal ...

GIMV Investeringsmaatschappij Voor Vlanderen NV published this content on 15 July 2021 and is solely responsible for the information contained therein.

Miniject: Harnessing the Drainage Power of the Supraciliary Space

iStar Medical receives US FDA approval to start pivotal trial for Miniject in glaucoma patients [press release]. iStar Medical. July 15, 2021. Accessed ...

iSTAR Medical | Gimv

AbbVie and iSTAR Medical Announce Strategic Alliance for the Treatment of Glaucoma · iSTAR Medical receives U.S. FDA approval to start pivotal ...

iStar Medical Receives FDA Nod to Begin Trial for MINIject MIGS ...

Get breaking ophthalmic news, device and drug updates, clinical trial coverage, thought-leader perspective, and industry announcements.

FDA Grants Approval to iSTAR Medical for Clinical Trial for MINIject

The U.S. Food and Drug Administration (FDA) has granted iSTAR Investigational Device Exemption (IDE) approval for to begin a trial with ...

iSTAR Medical: Home

iSTAR Medical received European approval for the MINIject MIGS device in ... approved clinical trial (STAR-V) in the United States in 2021. Since 2023 ...

iSTAR Medical shows initial positive progress of US STAR-V trial for ...

... US, has received positive feedback from glaucoma surgeons involved in the trial ... The STAR-V trial is a US FDA-approved pivotal study assessing ...

iSTAR Medical's MINIject shows consistent results at 18-month ...

... pivotal European trial. The results of STAR-II ... trial-18-month-results-EN.pdf. Source: iSTAR Medical ... receives U.S. FDA approval to start pivotal ...